Anlotinib Combined With Chemotherapy for the Treatment of HER2 Negative Advanced Breast Cancer
Clinical trial NCT05334147 · UNKNOWN
Trial details
- NCT number
- NCT05334147
- Sponsor
- The First Affiliated Hospital with Nanjing Medical University
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2022-04-15
- Primary completion
- 2025-02-01
- Enrollment
- 315
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.